Submit To AHA's Emerging Science™ Series!

ESS12headerbanner.jpg

Protecting Cerebrovascular Function- From Translational 
Science to Clinical Trials

Moderators: Robert O Bonow, Elliott Antman and Robert Harrington

 

Panelists: Jeffrey Weitz, John M Murkin and Mark Clay

 

Presentation:

Outcomes of Discontinuing Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Analysis from the ROCKET AF Trial  

Jonathan P Piccini, Duke Clinical Res Inst, Duke Univ Medical Ctr, Durham, NC  

 

Discussion Q&A  

 

Presentation:

Cerebrovascular Autoregulation Impairment is Associated with Elevations in Plasma Glial Fibrillary Acidic Protein During Congenital Heart Surgery

Ronald B Easley, Baylor Coll of Med, Houston, TX

 

Discussion Q&A 

  


Questions or Comments?

Abstract Submission
Email: support@abstractsonline.com   
Phone: 217-398-1792
General Information
Email: sessions@heart.org   
Online: scientificsessions.org
Posted by Alyson PON Editor on Apr 27, 2012 9:54 AM America/Chicago

Leave a Comment


Log in to post a comment.